Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine
A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is formulated to promote absorption through the buccal, sublingual, pharyngeal and/or esophageal mucous...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | est |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ANTHONY CLARKE EDWARD STEWART JOHNSON FRANCESCA MARY BREWER |
| description | A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is formulated to promote absorption through the buccal, sublingual, pharyngeal and/or esophageal mucous membranes, such that at least 5% of the active ingredient is absorbed in one minute, as determined by a buccal absorption test. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EE04039B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EE04039B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EE04039B13</originalsourceid><addsrcrecordid>eNqFy70KwkAQBOBrLER9BdkHUIjExjaS4APYh0VHOO9nj9uNz68Re6thPmaWbhy4JjbFZD76DAqSiqg39SKZCqpU5qgISonzpMbJz21HihhBL44f-GoCTO70ZAqs00wZa7d4zPfNL1duO_TX82WPIiO08A0ZNvZ9c2zaU3do_w7eLH49mA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine</title><source>esp@cenet</source><creator>ANTHONY CLARKE ; EDWARD STEWART JOHNSON ; FRANCESCA MARY BREWER</creator><creatorcontrib>ANTHONY CLARKE ; EDWARD STEWART JOHNSON ; FRANCESCA MARY BREWER</creatorcontrib><description>A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is formulated to promote absorption through the buccal, sublingual, pharyngeal and/or esophageal mucous membranes, such that at least 5% of the active ingredient is absorbed in one minute, as determined by a buccal absorption test.</description><edition>6</edition><language>est</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030616&DB=EPODOC&CC=EE&NR=04039B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030616&DB=EPODOC&CC=EE&NR=04039B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANTHONY CLARKE</creatorcontrib><creatorcontrib>EDWARD STEWART JOHNSON</creatorcontrib><creatorcontrib>FRANCESCA MARY BREWER</creatorcontrib><title>Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine</title><description>A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is formulated to promote absorption through the buccal, sublingual, pharyngeal and/or esophageal mucous membranes, such that at least 5% of the active ingredient is absorbed in one minute, as determined by a buccal absorption test.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFy70KwkAQBOBrLER9BdkHUIjExjaS4APYh0VHOO9nj9uNz68Re6thPmaWbhy4JjbFZD76DAqSiqg39SKZCqpU5qgISonzpMbJz21HihhBL44f-GoCTO70ZAqs00wZa7d4zPfNL1duO_TX82WPIiO08A0ZNvZ9c2zaU3do_w7eLH49mA</recordid><startdate>20030616</startdate><enddate>20030616</enddate><creator>ANTHONY CLARKE</creator><creator>EDWARD STEWART JOHNSON</creator><creator>FRANCESCA MARY BREWER</creator><scope>EVB</scope></search><sort><creationdate>20030616</creationdate><title>Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine</title><author>ANTHONY CLARKE ; EDWARD STEWART JOHNSON ; FRANCESCA MARY BREWER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EE04039B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>est</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANTHONY CLARKE</creatorcontrib><creatorcontrib>EDWARD STEWART JOHNSON</creatorcontrib><creatorcontrib>FRANCESCA MARY BREWER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANTHONY CLARKE</au><au>EDWARD STEWART JOHNSON</au><au>FRANCESCA MARY BREWER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine</title><date>2003-06-16</date><risdate>2003</risdate><abstract>A fast dispersing solid pharmaceutical composition having a monoamine oxidase B inhibitor as the only active ingredient is disclosed for the treatment of Parkinson's disease. The composition is formulated to promote absorption through the buccal, sublingual, pharyngeal and/or esophageal mucous membranes, such that at least 5% of the active ingredient is absorbed in one minute, as determined by a buccal absorption test.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | est |
| recordid | cdi_epo_espacenet_EE04039B1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Farmatseutiline kompositsioon peroraalseks manustamiseks, selle valmistamismeetod ja kasutamine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A03%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANTHONY%20CLARKE&rft.date=2003-06-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEE04039B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |